Zobrazeno 1 - 10
of 153
pro vyhledávání: '"Chafika Mazouni"'
Autor:
Elisabeth Chéreau, Catherine Uzan, Emmanuelle Boutmy-Deslandes, Sarah Zohar, Corinne Bézu, Chafika Mazouni, Jean-Rémi Garbay, Emile Daraï, Roman Rouzier
Publikováno v:
PLoS ONE, Vol 11, Iss 6, p e0156096 (2016)
OBJECTIVE:The aim of this study was to assess the efficacy (response rate centered on 80%) of a somatostatin analog with high affinity for 4 somatostatin receptors in reducing the postoperative incidence of symptomatic lymphocele formation following
Externí odkaz:
https://doaj.org/article/5c198a1168ff414f82fabe7e531dbc86
Autor:
Lajos Pusztai, Gabriel N. Hortobagyi, Bryan T. Hennessy, Massimo Cristofanilli, Chafika Mazouni, Fabrice Andre, Attila Tordai, W. Fraser Symmans, Cornelia Liedtke, Marjorie C. Green, Ana M. Gonzalez-Angulo, Kenneth R. Hess, Jaime A. Mejia
Publikováno v:
Journal of Clinical Oncology. 41:1809-1815
PURPOSE Triple-negative breast cancer (TNBC) is defined by the lack of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER-2) expression. In this study, we compared response to neoadjuvant chemotherap
Autor:
E. Charaffe Jauffret, Gilles Houvenaeghel, P. Gimbergues, Armando J. Martínez, Aubert Agostini, Emile Daraï, A. De Nonneville, Chafika Mazouni, Nicolas Chopin, Pierre-Emmanuel Colombo, Xavier Muracciole, Marie Bannier, A.-S. Azuar, C. Tunon de Lara, Monique Cohen, M.-P. Chauvet, Roman Rouzier, Fabien Reyal, J-M Classe, Anthony Gonçalves, Charles Coutant
Publikováno v:
ESMO Open
ESMO Open, 2021, 6 (6), pp.100316. ⟨10.1016/j.esmoop.2021.100316⟩
ESMO Open, European Society for Medical Oncology, 2021, 6 (6), pp.100316. ⟨10.1016/j.esmoop.2021.100316⟩
ESMO Open, 2021, 6 (6), pp.100316. ⟨10.1016/j.esmoop.2021.100316⟩
ESMO Open, European Society for Medical Oncology, 2021, 6 (6), pp.100316. ⟨10.1016/j.esmoop.2021.100316⟩
Background We determined the prognostic impact of lymphovascular invasion (LVI) in a large, national, multicenter, retrospective cohort of patients with early breast cancer (BC) according to numerous factors. Patients and methods We collected data on
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc60d01846b2b9c53d5fd1fc100b1753
https://hal.sorbonne-universite.fr/hal-03468643
https://hal.sorbonne-universite.fr/hal-03468643
Autor:
Muriel Abbaci, Frederic De Leeuw, Angelica Conversano, Corinne Laplace-Builhé, Chafika Mazouni
Publikováno v:
EJSO-European Journal of Surgical Oncology
EJSO-European Journal of Surgical Oncology, WB Saunders, 2019, 45, pp.1778-1786. ⟨10.1016/j.ejso.2019.06.009⟩
EJSO-European Journal of Surgical Oncology, WB Saunders, 2019, 45, pp.1778-1786. ⟨10.1016/j.ejso.2019.06.009⟩
Sentinel lymph node identification by near infrared (NIR) fluorescence with indocyanine green (ICG) is recognized in the literature as a useful technique. NIR fluorescence technology could become key in the prevention and management of lymphedema aft
Autor:
Stefan Michiels, M. Cortet, Carole Mathelin, C. Tunon, Frédéric Marchal, Monique Cohen, Cécile Charles, L. Boulanger, D. Boinon, Flore Salviat, A. Favier, A.-V. Salomon, C. Vaysse, Suzette Delaloge, Isabelle Doutriaux-Dumoulin, V. Fermeaux, Veronique Boussion, Charles Coutant, Catherine Uzan, M. Espie, Chafika Mazouni, B. De Korvin, Nathalie Chabbert-Buffet, Sonia Zilberman
Publikováno v:
Gynécologie Obstétrique Fertilité & Sénologie
Gynécologie Obstétrique Fertilité & Sénologie, Elsevier, 2021, ⟨10.1016/j.gofs.2021.09.010⟩
Gynécologie Obstétrique Fertilité & Sénologie, Elsevier, 2021, ⟨10.1016/j.gofs.2021.09.010⟩
INTRODUCTION: Organized and individual breast screening have been accompanied by an increase in the detection of "atypical breast lesions "(ABL). Recently, the NOMAT multicenter study proposed a predictive model of the risk of developing breast cance
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae869ba812aa56d8e3b047580329f969
https://hal.archives-ouvertes.fr/hal-03467510
https://hal.archives-ouvertes.fr/hal-03467510
Autor:
P. Gimbergues, Roman Rouzier, X Murraciole, Nicolas Chopin, Monique Cohen, Eric Lambaudie, M.-P. Chauvet, G. Houvenaeghel, P-E. Colombo, Chafika Mazouni, Aubert Agostini, A. Gonçalves, J-M Classe, A.-S. Azuar, Armando J. Martínez, Emile Daraï, A. De Nonneville, C. Tunon de Lara, Fabien Reyal, Charles Coutant
Publikováno v:
Cancer Research. 79:P2-08
Background Tumour features associated with isolated invasive breast cancer ipsilateral local recurrence (ILR) after breast conservative treatment (BCT) and consequences on overall survival (OS) are still debated. The aim of our study was to examine p
Autor:
Almudena Maria Cascales-Garcia, Marie-Christine Mathieu, Chafika Mazouni, Sofia Rivera, Ariane Dunant, Rodrigo Arriagada, Mauro Loi, Eric Deutsch, Sahar Ghith, Barbara Pistilli
Publikováno v:
Cancer Investigation. 37:29-38
Purpose To assess predictors of outcome in a cohort of Inflammatory Breast Cancer (IBC) patients receiving induction chemotherapy followed by local treatment. Methods We retrospectively reviewed 95 non-metastatic IBC patient files. Results Complete c
Autor:
Frederic De Leeuw, Angelica Conversano, Corinne Laplace-Builhé, Heba Alkhashnam, Meriem Koual, Nicolas Leymarie, Françoise Rimareix, Chafika Mazouni, Muriel Abbaci
Publikováno v:
The Breast Journal. 24:1006-1009
We compared the performance of near-infrared imaging using indocyanine green (ICG) with the radioisotope (ISO) method to detect sentinel lymph nodes (SLNs) in breast cancer, to analyze predictive factors for negative ICG identification. The study inc
Autor:
Véronique Scott, Alexander Valent, Ivan Bièche, Suzette Delaloge, Mohamed Amine Bayar, I. Bouakka, Fabrice Andre, Corinne Balleyguier, Audrey Rapinat, Stefan Michiels, David Gentien, V. Leroux-Kozal, Magali Lacroix-Triki, Chafika Mazouni, Virginie Marty, Bianca Cheaib, Monica Arnedos, Benjamin Sarfati, Julien Adam
Publikováno v:
Annals of Oncology. 29:1755-1762
The cyclin-dependent kinase 4 (CDK4)/6 inhibitor Palbociclib is a new standard treatment in hormone-receptor positive breast cancer patients. No predictive biomarkers have been identified and no pharmacodynamics has properly been described so far.Pat
Autor:
Isabelle Miran, Dominique Scherer, Pauline Ostyn, Chafika Mazouni, Françoise Drusch, Marine Bernard, Emilie Louvet, Julien Adam, Marie-Christine Mathieu, Mariam Haffa, Jean-Philippe Antignac, Bruno Le Bizec, Philippe Vielh, Philippe Dessen, Hervé Perdry, Suzette Delaloge, Jean Feunteun
Publikováno v:
Frontiers in Oncology
Frontiers in Oncology, 2020, 10, ⟨10.3389/fonc.2020.01506⟩
Frontiers in Oncology, Vol 10 (2020)
Frontiers in Oncology, Frontiers, 2020, 10, ⟨10.3389/fonc.2020.01506⟩
Frontiers in Oncology, 2020, 10, ⟨10.3389/fonc.2020.01506⟩
Frontiers in Oncology, Vol 10 (2020)
Frontiers in Oncology, Frontiers, 2020, 10, ⟨10.3389/fonc.2020.01506⟩
International audience; The tissue stroma plays a major role in tumors' natural history. Most programs for tumor progression are not activated as cell-autonomous processes but under the conditions of cross-talks between tumor and stroma. Adipose tiss